Tau buildup in brainstem region triggers hyperactivity and early Alzheimer's-like symptoms in mice
Researchers found that pathogenic tau in the locus coeruleus of mice leads to overactive noradrenergic signaling. This hyperactivity produces neuropsychiatric behaviors resembling early Alzheimer's disease. The findings highlight the locus coeruleus as a key site in Alzheimer's pathology.
The locus coeruleus, a small brainstem region, is emerging as a critical early player in Alzheimer's disease progression. In this study, researchers observed that pathogenic tau accumulation in this area triggered excessive noradrenergic signaling—the system tied to alertness and stress responses. This overactivity corresponded with hyperactive behaviors in mice that mirror neuropsychiatric symptoms seen in early-stage Alzheimer's patients, such as agitation or restlessness.
These findings suggest that tau's effects may begin in the brainstem before spreading to other regions. By pinpointing the locus coeruleus as a site where tau pathology disrupts normal signaling, the research offers a more precise target for studying how early behavioral changes emerge. It underscores that Alzheimer's involves not just memory circuits but also systems governing arousal and emotional regulation.
This research could reshape how early Alzheimer's is understood and detected, particularly the neuropsychiatric symptoms that often precede memory loss. Clinicians may eventually use locus coeruleus activity as an early biomarker, while drug developers could target noradrenergic signaling to delay symptom onset. Patients and caregivers might benefit from earlier interventions, though translating mouse findings to humans remains uncertain. The work may also encourage broader screening for behavioral changes in at-risk populations, potentially improving quality of life through earlier support.